A remarkable and lucky fact about the skin is that it is the one organ in humans that is amenable to local and systemic treatment.  For example, consider the treatment of skin irritations, e.g. atopic dermatitis.  Typically, in such an instance, your clinician may prescribe a systemic antibiotic concomitant with a local anti-inflammatory.

Because hair follicles are essentially ectodermal appendages of the skin, the same principle applies.  And one of the earliest hypotheses that rendered HairGenesis® unique in the category was our concomitant local and systemic treatment approach.  Here, we built the HairGenesis® regimen around the concept that the best way to treat a condition like pattern hair loss would be to attack the problem systemically via an oral formula and locally via a topical preparation.  

Fifteen years later, we are still on the leading edge.  

Building on what we've learned through more than a decade of solid research, our new Generation IV and V formulations are the first to demonstrate utility against pathologic inflammation of the hair follicle.   Thus, HairGenesis® now operates as a dual-mode (topical/systemic) dual-mechanism (anti-inflammatory/DHT blockade) therapy.  

Here's why this is important for you.

The new thinking in hair loss research is built on the recognition that turning down the androgen metabolism rheostat (via DHT blockade) is only one piece of the puzzle.  Inflammation in the hair follicle seems to be another highly important factor.  Therefore, ideally, it is probably best to deploy a dual-mode treatment against pattern hair loss, i.e. one that blocks DHT while simultaneously reducing problematic inflammation.  This is where HairGenesis® constitutes a unique option in the hair loss treatment category.  No other brand does what HairGenesis® does.  

HairGenesis® really works.  You can bet your hair on it!